Stockscreener 앱 받기
58.56
1.28%
-0.7579
전일 마감가:
$59.31
열려 있는:
$58.32
하루 거래량:
1,844
Relative Volume:
0.58
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+0.06%
1개월 성능:
+5.40%
6개월 성능:
-3.30%
1년 성능:
-1.14%
1일 변동 폭
$58.31
$58.58
1주일 범위
$57.61
$59.38
52주 변동 폭
$48.65
$69.12
Virtus Lifesci Biotech Products Etf Stock (BBP) Company Profile
BBP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBP
Virtus Lifesci Biotech Products Etf
|
58.56 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
299.36 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
607.12 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
609.96 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
233.78 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
541.16 | 124.43B | 0 | 0 | 0 | 0.00 |
Virtus Lifesci Biotech Products Etf 주식(BBP)의 최신 뉴스
(BBP) Long Term Investment Analysis - news.stocktradersdaily.com
How the (BBP) price action is used to our Advantage - news.stocktradersdaily.com
Vinay Prasad's Appointment To FDA's CBER Triggers Questions Over Future Of Cell And Gene Therapy Regulation - Benzinga
(BBP) Pivots Trading Plans and Risk Controls - news.stocktradersdaily.com
Merck Germany Buys US Cancer Drugmaker SpringWorks Therapeutics For Around $4 Billion - Benzinga
6 Best-Performing ETFs of Last Week - TradingView
When the Price of (BBP) Talks, People Listen - news.stocktradersdaily.com
Gate Q1 2025 Transparency Report: Sustained Leadership in Crypto Markets with Multiple Metrics Hitting New Highs - GlobeNewswire Inc.
(BBP) Investment Analysis - news.stocktradersdaily.com
Learn to Evaluate (BBP) using the Charts - news.stocktradersdaily.com
(BBP) Technical Data - news.stocktradersdaily.com
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
(BBP) On The My Stocks Page - Stock Traders Daily
When (BBP) Moves Investors should Listen - Stock Traders Daily
SBIO, XBI, or BBP: Which is the Best Biotech ETF, According to Analysts? - Nasdaq
4 Best-Performing Sector ETFs of June - Nasdaq
9 Best Biotech ETFs for 2024 - MSN
The 5 Best Biotech ETFs of 2024 - ETF.com
5 Best Biotech ETFs To Buy - Insider Monkey
This biotech ETF sees ‘breakout’ while U.S. small-cap technology stocks lag - MarketWatch
Biotech ETFs Stage Solid Comeback at the Start of 2024 - Nasdaq
10 Best Performing Healthcare ETFs in 2023 - Yahoo Finance
12 Best Biotech ETFs To Buy - Yahoo Finance
GMAB: Invest in These 3 High-Growth Biotech Stocks - StockNews
Biotechnology - etf.com
Biotech - etf.com
Sectors - etf.com
Healthcare - etf.com
5 Least-Hurt Biotech ETFs of the Last Week - Yahoo Finance
Innovation Reigns In 10 Best-Performing ETFs Of The Last 3 Months - Financial Advisor (Mag)
Biotech & Crypto -- Best ETF Areas of Last Week - Nasdaq
Biotech ETFs Advance on Speculation of a Takeover Bid for Global Blood Therapeutics - ETF Trends
5 ETFs Riding High on the Biotech Comeback - Yahoo Finance
Biotech ETFs Are Making a Comeback - ETF Trends
Betting on Biotech Bear Market Expiration Date - ETF Trends
Biotech ETFs That Outperformed Last Week - Yahoo Finance
4 Biotech ETFs to Know About. Gain exposure to companies working on… | by Tunji Onigbanjo - DataDrivenInvestor
Best And Worst Q1 2021: Healthcare ETFs And Mutual Funds - Seeking Alpha
Want to Use ETFs to Play Biotech? Choose Wisely. - Barron's
15 Best Performing ETFs of 2019 - ETF Trends
The Medicines Company Soars Amid Acquisition Whispers - Investopedia
Healthcare innovators - Etrade
Top Healthcare ETFs Right Now • Updated Daily - Benzinga
Biotech Company Cara Therapeutics (CARA) Up 15% - ETF Trends
8 High Flying Biotech ETFs for 2019 - ETF Trends
Biotechnology ETF List - ETFdb.com
An ETF That Aims to Capitalize on Upcoming Drug Breakthroughs - Investopedia
ETF of the Week: Virtus LifeSci Biotech Clinical Trials ETF (BBC) - ETF Trends
Sarepta Pharma Pushes Two Biotech ETFs to New Highs - Nasdaq
Try This ETF Pair to Round Out Biotech Exposure - ETF Trends
10 ETFs That Will Keep Your Portfolio in Good Health - Money/ US News
Virtus Lifesci Biotech Products Etf (BBP) 재무 분석
Virtus Lifesci Biotech Products Etf (BBP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
0.54%
0.45%
자본화:
|
볼륨(24시간):